Compare DRIO & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRIO | GDO |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.1M | 87.4M |
| IPO Year | N/A | N/A |
| Metric | DRIO | GDO |
|---|---|---|
| Price | $10.76 | $11.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 10.5K | ★ 39.4K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,732,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.29 | N/A |
| 52 Week Low | $5.94 | $11.21 |
| 52 Week High | $17.74 | $13.04 |
| Indicator | DRIO | GDO |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 40.33 |
| Support Level | $9.94 | $11.55 |
| Resistance Level | $11.13 | $11.71 |
| Average True Range (ATR) | 0.57 | 0.11 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 32.22 | 24.14 |
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.